These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30333830)

  • 21. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
    Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
    Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
    Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
    Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
    Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
    J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways.
    Qu R; Chen X; Hu J; Fu Y; Peng J; Li Y; Chen J; Li P; Liu L; Cao J; Wang W; Qiu C; Guo L; Vasilev K; Chen J; Zhou G; Li W; Zhao Y
    Sci Rep; 2019 Feb; 9(1):1348. PubMed ID: 30718736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic difference between C57Bl/6J and C57Bl/6N mice significantly impacts Aldara™-induced psoriasiform dermatitis.
    Bezdek S; Hdnah A; Sezin T; Mousavi S; Zillikens D; Ibrahim S; Ludwig RJ; Sadik CD
    Exp Dermatol; 2017 Apr; 26(4):349-351. PubMed ID: 27315297
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
    Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
    J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
    Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression.
    Honda A; Abe R; Makino T; Norisugi O; Fujita Y; Watanabe H; Nishihira J; Iwakura Y; Yamagishi S; Shimizu H; Shimizu T
    J Dermatol Sci; 2008 Jan; 49(1):63-72. PubMed ID: 18060744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.
    Shibata S; Tada Y; Hau CS; Mitsui A; Kamata M; Asano Y; Sugaya M; Kadono T; Masamoto Y; Kurokawa M; Yamauchi T; Kubota N; Kadowaki T; Sato S
    Nat Commun; 2015 Jul; 6():7687. PubMed ID: 26173479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization.
    Liu J; Qiu C; Zhou Z; Li J; Zhen Y; Wang R; Zhuang Y; Zhang F
    Int Immunopharmacol; 2024 Mar; 130():111805. PubMed ID: 38457930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease.
    Zhao W; Xiao S; Li H; Zheng T; Huang J; Hu R; Zhang B; Liu X; Huang G
    Front Immunol; 2018; 9():569. PubMed ID: 29619028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.
    Nagata Y; Yoshihisa Y; Matsunaga K; Rehman MU; Kitaichi N; Shimizu T
    PLoS One; 2015; 10(2):e0115593. PubMed ID: 25647395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
    Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
    J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Chong HT; Yang GN; Sidhu S; Ibbetson J; Kopecki Z; Cowin AJ
    Br J Dermatol; 2017 Mar; 176(3):705-712. PubMed ID: 27373931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.
    Pantelyushin S; Haak S; Ingold B; Kulig P; Heppner FL; Navarini AA; Becher B
    J Clin Invest; 2012 Jun; 122(6):2252-6. PubMed ID: 22546855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.